Cough Medication: Evidence-Based Recommendations

Acute Cough (< 3–4 weeks)

For acute cough in adults and children, over-the-counter cough medications provide no proven benefit and should not be used. 1

Acute cough is most commonly viral and self-limiting, requiring only supportive care 1
Patients report subjective benefit from OTC preparations, but there is little evidence of specific pharmacological effect 1
Do not give over-the-counter cough or cold medications to children—they provide no therapeutic benefit and may cause harm 2
Antibiotics are not indicated for acute viral cough lasting < 4 weeks without signs of bacterial infection 3

When to Investigate Acute Cough Further

Pursue further workup if any of the following are present:

Hemoptysis 1
Prominent systemic illness 1
Suspicion of inhaled foreign body 1
Suspicion of lung cancer 1

Chronic Cough in Adults (> 8 weeks)

Initial Evaluation

All adults with chronic cough require chest radiograph and spirometry as mandatory first steps. 1

Most chronic cough in adults results from upper airway cough syndrome (postnasal drip), asthma, gastroesophageal reflux disease, or nonasthmatic eosinophilic bronchitis 1, 4, 5
These four conditions account for 90% of chronic cough cases 5
The character, timing, and complications of cough do not reliably predict the underlying cause 5

Treatment Algorithm for Adults

1. Stop ACE inhibitors immediately if the patient is taking one—cough is unlikely to be corticosteroid-responsive if it persists after ACE inhibitor cessation. 1

2. For suspected asthma or eosinophilic bronchitis:

Trial of inhaled corticosteroids (400 mcg/day budesonide equivalent) for 2 weeks 6
If no response after 2 weeks of oral steroids, cough is unlikely due to eosinophilic airway inflammation 1

3. For suspected GERD:

Proton pump inhibitor (omeprazole 40 mg daily or equivalent) plus dietary modification and lifestyle changes 7
Add prokinetic therapy (metoclopramide 10 mg four times daily) if PPI alone is ineffective 7
Treatment may take 8 weeks or longer to show benefit; some patients require months 7

4. For refractory chronic cough (failed empiric trials):

Low-dose morphine is highly effective in a subset of patients with cough resistant to other treatments 8
Gabapentin or pregabalin can be tried, though limited by adverse events 8, 4
Dextromethorphan: effect size 0.37 for cough severity (95% CI 0.19–0.56, P = 0.0008) 9
Opioid antitussives: effect size 0.55 for cough severity (95% CI 0.38–0.72, P < 0.0001) 9
Speech therapy/cough suppression therapy when performed by competent practitioners 8

Benzonatate (FDA-Approved Antitussive)

For adults and children over 10 years: 100–200 mg three times daily as needed; maximum 600 mg daily in three divided doses 10

Critical safety warning: Benzonatate capsules must be swallowed whole—never broken, chewed, dissolved, cut, or crushed 10

Chronic Cough in Children (> 4 weeks)

Initial Classification

First, determine whether the cough is wet/productive or dry/non-productive—this distinction drives all subsequent management. 11

Wet/productive cough suggests protracted bacterial bronchitis, bronchiectasis, or chronic suppurative lung disease 11
Dry/non-productive cough may represent post-viral cough, asthma, or non-specific cough 11

Mandatory Initial Investigations

Obtain chest radiograph and spirometry (if child ≥ 3–6 years old) for all children with chronic cough. 6, 11

Red Flags ("Specific Cough Pointers")

Immediate further investigation required if any of the following are present:

Coughing with feeding 12, 11
Digital clubbing 12, 11
Hemoptysis 11
Failure to thrive 12
Abnormal chest radiograph or spirometry 6, 11

Management Algorithm for Wet/Productive Cough in Children

1. First-line treatment (no specific pointers present):

Prescribe 2 weeks of antibiotics targeting Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis based on local antibiotic sensitivities 12
Amoxicillin-clavulanate is the most commonly used regimen 3
If cough resolves within 2 weeks, diagnose protracted bacterial bronchitis (PBB) 12

2. If cough persists after 2 weeks:

Extend antibiotics for an additional 2 weeks 12, 3

3. If cough persists after 4 weeks total:

Proceed to further investigations: flexible bronchoscopy with quantitative cultures, chest CT, assessment for aspiration, evaluation of immunologic competency 12, 11
Refer to pediatric pulmonology 11

Management Algorithm for Dry/Non-Productive Cough in Children

1. Initial approach (no specific pointers present):

Adopt a "watch, wait, and review" strategy—most cases are post-viral and resolve spontaneously 6, 11
Review in 2–4 weeks to assess for resolution or development of specific pointers 11

2. Do NOT empirically treat for asthma unless:

Cough worsens at night 2
Episodes triggered by exercise or irritants 2
Family history of asthma or atopy 2
Other features consistent with asthma are present 11

3. If empirical trial of inhaled corticosteroids is warranted:

Use 400 mcg/day budesonide equivalent for 2–3 weeks 6
If no response, cease ICS and reconsider diagnosis 6, 11

4. If dry cough persists > 4 weeks:

Perform systematic evaluation for chronic cough with chest radiograph and spirometry 11
Consider flexible bronchoscopy if severe, persistent, or atypical presentation—68% of such infants have associated lower airway abnormalities 2

Environmental and Supportive Measures

Eliminate tobacco smoke exposure—this is a major contributor to chronic cough in both adults and children. 11, 13

Ensure adequate hydration to thin secretions and facilitate clearance 11
Avoid chest physiotherapy—it offers no benefit and may cause harm 2
Antipyretics can be used for comfort in febrile children 2

Critical Pitfalls to Avoid

Never use combination cough preparations—they should not be prescribed 13
Never give OTC cough medications to children—they lack proven efficacy and carry risk of serious adverse effects 2, 11
Never give antihistamines or decongestants for cough—they are ineffective and carry potential adverse effects 2
Never use honey for acute cough—it is only helpful for post-viral cough, not inflammatory airway conditions 2
Never empirically treat for GERD, asthma, or upper airway cough syndrome without specific clinical features supporting these diagnoses 11
Never discharge a child within 2 hours of nebulized epinephrine (if given for croup-like presentation) due to risk of rebound symptoms 2

What are the recommended cough medications for dry versus productive coughs, considering patient age, comorbidities, and contraindications?

Have a follow-up question?